Abstract: The present invention relates to a tablet comprising one or more omega-3 fatty acid amino acid salt(s), a method for preparing a tablet according to the invention and the use of a tablet according to the invention as a food supplement or as a pharmaceutical product.

Abstract: A coated composition for feeding a ruminant may include: (A) a core of a biologically active ingredient selected from (A-i) amino acids, N-acylamino acids, N-guanylamino acids, and/or salts thereof and/or 2-hydroxy-4-(methyl)butyric acid calcium salt; (A-ii) proteins; (A-iii) peptides; (A-iv) carbohydrates; (A-v) vitamins, vitamin A (acetate or palmitate), B, D2, D3, E, thiamine (HCl), riboflavin, nicotinic acid (amide), calcium pantothenate, choline pantothenate, pyridoxine hydrochloride, choline chloride, cyano-cobalamin, biotin, folic acid, and p-aminobenzoic acid; (A-vi) probiotic microorganisms; (A-vii) prebiotic foods; (A-viii) choline and salts thereof; (A-ix) polyunsaturated fatty acids, and salts thereof; and x) any combination of (A-i) to (A-ix); and (B) a coating, encapsulating the core, constituting 1 to 15% of total coated composition weight and including 85 to 95% wt./wt. of a film-forming agent, which is triethyl citrate, and 5 to 15% wt./wt.

Abstract: The present invention relates to a tablet comprising one or more omega-3 fatty acid amino acid salts, a method for preparing a tablet according to the invention and the use of a tablet according to the invention as a food supplement or as a pharmaceutical product.

Abstract: The present invention relates to a tablet comprising one or more omega-3 fatty acid amino acid salts, a method for preparing a tablet according to the invention and the use of a tablet according to the invention as a food supplement or as a pharmaceutical product.

Abstract: The present invention relates to a tablet comprising one or more omega-3 fatty acid amino acid salt(s), a method for preparing a tablet according to the invention and the use of a tablet according to the invention as a food supplement or as a pharmaceutical product.

Abstract: The present invention relates to a gastric retention active delivery system in the form of a coated capsule, which, in contrast to prior art delivery systems exhibiting relatively poor floating-properties, and thus requiring size expansion capability in order to securely delay passage through the pylorus, reliably stay afloat for several hours. This is achieved by combining pore forming components and flexible polymer components in the coating in suitable proportions. The present invention, further, relates to the use of gastric retention active delivery systems of the invention for the delivery of one or more water soluble active components A to a mammal.

Abstract: The present invention relates to a gastric retention active delivery system in the form of a coated capsule, which, in contrast to prior art delivery systems exhibiting relatively poor floating-properties, and thus requiring size expansion capability in order to securely delay passage through the pylorus, reliably stay afloat for several hours. This is achieved by combining pore forming components and flexible polymer components in the coating in suitable proportions. The present invention, further, relates to the use of gastric retention active delivery systems of the invention for the delivery of one or more water soluble active components A to a mammal.